High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry

References

• Chermack ST, Roll J, Reilly M, Davis L, Kilaru U, Grabowski J. Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. Drug Alcohol Depend 2000;59:43–49
   PubMed Web of Science ®Google Scholar
• Ries RK, Dyck DG, Short R, Srebnik D, Snowden M, Comtois KA. Use of case manager ratings and weekly urine toxicology tests among outpatients with dual diagnoses. Psychiatr Serv 2002;53:764–766
   PubMed Web of Science ®Google Scholar
• Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depend 2004;74:223–234
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Treatment episode dataset 1999–2009: National admissions to substance abuse treatment services 2011
   Google Scholar
• Zuba D. Accuracy and reliability of breath alcohol testing by handheld electrochemical analysers. Forensic Sci Int 2008;178:29–33
   PubMed Web of Science ®Google Scholar
• Gurvich EM, Kenna GA, Leggio L. Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials. Alcohol Alcoholism 2013;48:712–719
   PubMed Web of Science ®Google Scholar
• Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci 1980;12:1–5
   PubMed Web of Science ®Google Scholar
• Rosalki SB. Gamma-glutamyl transpeptidase. Adv Clin Chem 1975;17:53–107
   PubMedGoogle Scholar
• Helander A, Peter O, Zheng Y. Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting. Alcohol Alcoholism 2012;47:552–557
   PubMed Web of Science ®Google Scholar
• Varga A, Hansson P, Johnson G, Alling C. Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin Chim Acta 2000;299:141–150
   PubMed Web of Science ®Google Scholar
• Wurst F, Thon N, Aradottir S, Hartmann S, Wiesbeck G, Lesch O, Skala K, et al. Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports. Addict Biol 2010;15:88--95
   PubMed Web of Science ®Google Scholar
• Helander A, Beck O. Ethyl sulfate: a metabolite of ethanol in humans and a potential biomarker of acute alcohol intake. J Anal Toxicol 2005;29:270–274
   PubMed Web of Science ®Google Scholar
• Wurst F, Dresen S, Allen JP, Wiesbeck G, Graf M, Weinmann W. Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. Addiction 2006;101:204–211
   PubMed Web of Science ®Google Scholar
• Helander A, Böttcher M, Fehr C, Dahmen N, Beck O. Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Alcohol Alcoholism 2008;44:55–61
   PubMed Web of Science ®Google Scholar
• Crunelle CL, Yegles M, van Nuijs AL, Covaci A, De Doncker M, Maudens KE, Sabbe B, et al. Hair ethyl glucuronide levels as a marker for alcohol use and abuse: a review of the current state of the art. Drug Alcohol Depend 2014;134:1–11
   PubMed Web of Science ®Google Scholar
• Böttcher M, Beck O, Helander A. Evaluation of a new immunoassay for urinary ethyl glucuronide testing. Alcohol Alcoholism 2008;43:46–48
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). The role of biomarkers in the treatment of alcohol use disorders. SAMHSA Advisory 2012;11
   Google Scholar
• McDonell MG, Srebnik D, Angelo F, Sugar AM, Howell D, Rainey C, Roll J, et al. Evaluation of ethyl glucuronide immunoassay urinalysis in five alcohol dependent outpatients. Am J Addiction 2011;20:482–484
   PubMed Web of Science ®Google Scholar
• Rosano TG, Lin J. Ethyl glucuronide excretion in humans following oral administration of and dermal exposure to ethanol. J Anal Toxicol 2008;32:594–600
   PubMed Web of Science ®Google Scholar
• Albermann ME, Musshoff F, Madea B. A high-performance liquid chromatographic-tandem mass spectrometric method for the determination of ethyl glucuronide and ethyl sulfate in urine validated according to forensic guidelines. J Chromatogr Sci 2012;50:51–56
   PubMed Web of Science ®Google Scholar
• Crews B, Latyshev S, Mikel C, Almazan P, West R, Pesce A, West C. Improved detection of ethyl glucuronide and ethyl sulfate in a pain management population using high-throughput LC-MS/MS. J Opioid Manag 2010;6:415–421
   PubMedGoogle Scholar
• Turfus SC, Vo T, Niehaus N, Gerostamoulos D, Beyer J. An evaluation of the DRI-ETG EIA method for the determination of ethyl glucuronide concentrations in clinical and post-mortem urine. Drug Test Anal 2013;5:439–445
   PubMed Web of Science ®Google Scholar
• Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 1994;6:284–290
   Google Scholar
• Warnes GR. gmodels: various R programming tools for model fitting [Computer software manual]. Available from: http://CRAN.R-project.org/package=gmodels (R package version 2.15.4.1) [last accessed 1 April 2014]
   Google Scholar
• R Core Team. R: a language and environment for statistical computing [Computer software manual]. Vienna, Austria: 2013. Available from: http://www.R-project.org/ [last accessed 1April 2014]
   Google Scholar
• Helander A, Dahl H. Urinary tract infection: a risk factor for false-negative urinary ethyl glucuronide but not ethyl sulfate in the detection of recent alcohol consumption. Clin Chem 2005;51:1728–1730
   PubMed Web of Science ®Google Scholar
• Jatlow P, O’Malley S. Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready? Alcohol Clin Exp Res 2010;34:968–975
   PubMed Web of Science ®Google Scholar